Skip to main content

Table 3 Crude associations of residency and secondary exposures with treatment success and loss to follow-up (n = 5502)

From: Tuberculosis among economic migrants: a cross-sectional study of the risk of poor treatment outcomes and impact of a treatment adherence intervention among temporary residents in an urban district in Ho Chi Minh City, Viet Nam

 

Treatment success

Loss to follow-up

RR‡

95% CI

p-valueÞ

OR‡

95% CI

p-valueÞ

Total

n/a

n/a

n/a

n/a

n/a

n/a

Residency

 Permanent¥

1.00

  

1.00

  

 Temporary

1.00

[0.97, 1.02]

0.736

1.63

[1.25, 2.13]

< 0.001

Residency

 KT1¥

1.00

  

1.00

  

 KT2

0.96

[0.89, 1.03]

0.246

1.89

[1.05, 3.39]

0.033

 KT3

1.03

[0.99, 1.08]

0.184

0.62

[0.31, 1.22]

0.167

 KT4

0.99

[0.95, 1.02]

0.504

2.07

[1.53, 2.79]

< 0.001

Sex

 Male¥

1.00

  

1.00

  

 Female

1.05

[1.03, 1.08]

< 0.001

0.78

[0.59, 1.04]

0.089

Age

  < 25 years¥

1.00

  

1.00

  

 25–34 years

0.95

[0.91, 0.98]

0.001

1.23

[0.86, 1.78]

0.260

 35–44 years

0.96

[0.92, 0.99]

0.015

0.84

[0.56, 1.26]

0.410

 45–54 years

0.97

[0.94, 1.00]

0.071

0.58

[0.37, 0.91]

0.016

  > 55 years

0.91

[0.87, 0.94]

< 0.001

0.55

[0.35, 0.86]

0.010

Patient type┼

 New¥

1.00

  

1.00

  

 Relapse

0.86

[0.82, 0.91]

< 0.001

1.02

[0.66, 1.58]

0.925

 Failure

0.61

[0.51, 0.73]

< 0.001

1.61

[0.74, 3.52]

0.232

 LTFU

0.82

[0.69, 0.97]

0.019

2.14

[0.84, 5.43]

0.109

 Unknown

0.94

[0.89, 0.99]

0.018

1.39

[0.86, 2.26]

0.182

 Transfer in

0.85

[2.05, 2.93]

< 0.001

1.66

[0.96, 2.87]

0.067

Type of TB§

 AFB(+)¥

1.00

  

1.00

  

 AFB(−)

1.09

[1.06, 1.12]

< 0.001

0.78

[0.55, 1.09]

0.143

 EP

1.07

[1.04, 1.10]

< 0.001

0.87

[0.64, 1.20]

0.398

HIV/AIDS¶

 No/Unknown¥

1.00

  

1.00

  

 Yes

0.78

[0.74, 0.83]

< 0.001

2.56

[1.90, 3.46]

< 0.001

Diabetes

 No/Unknown¥

1.00

  

1.00

  

 Yes

0.96

[0.91, 1.01]

0.145

0.87

[0.50, 1.51]

0.622

  1. Notes
  2. ‡Crude Risk Ratios and Odds Ratios calculated by univariate log binomial and logistic regression, respectively;
  3. ÞWald test;
  4. ¥Referent;
  5. ┼Failure = Retreatment after category I treatment failure; LTFU = Retreatment after loss to follow-up; Unknown = Retreatment with unknown/uncertain exposure to anti-TB drugs;
  6. §AFB(+) = Sputum smear positive; AFB(−) = Sputum smear negative; EP = Extra-pulmonary TB;
  7. ¶Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome;